Follow
Jennifer Bishop
Jennifer Bishop
Zymeworks, Inc
Verified email at zymeworks.com
Title
Cited by
Cited by
Year
The master neural transcription factor BRN2 is an androgen receptor–suppressed driver of neuroendocrine differentiation in prostate cancer
JL Bishop, D Thaper, S Vahid, A Davies, K Ketola, H Kuruma, R Jama, ...
Cancer discovery 7 (1), 54-71, 2017
3382017
PD-L1 is highly expressed in Enzalutamide resistant prostate cancer
JL Bishop, A Sio, A Angeles, ME Roberts, AA Azad, KN Chi, A Zoubeidi
Oncotarget 6 (1), 234, 2015
2762015
Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer
M Shiota, JL Bishop, KM Nip, A Zardan, A Takeuchi, T Cordonnier, ...
Cancer research 73 (10), 3109-3119, 2013
2282013
Salmonella: from Pathogenesis to Therapeutics
EC Boyle, JL Bishop, GA Grassl, BB Finlay
Journal of bacteriology 189 (5), 1489-1495, 2007
2002007
Subversion of the innate immune system by a retrovirus
BA Jude, Y Pobezinskaya, J Bishop, S Parke, RM Medzhitov, ...
Nature immunology 4 (6), 573-578, 2003
1912003
The multifaceted roles of STAT3 signaling in the progression of prostate cancer
JL Bishop, D Thaper, A Zoubeidi
Cancers 6 (2), 829-859, 2014
1412014
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
B Benzon, SG Zhao, MC Haffner, M Takhar, N Erho, K Yousefi, P Hurley, ...
Prostate cancer and prostatic diseases 20 (1), 28-35, 2017
1362017
A Novel Antiandrogen, Compound 30, Suppresses Castration-Resistant and MDV3100-Resistant Prostate Cancer Growth In Vitro and In Vivo
H Kuruma, H Matsumoto, M Shiota, J Bishop, F Lamoureux, C Thomas, ...
Molecular cancer therapeutics 12 (5), 567-576, 2013
1222013
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer
AW Wyatt, F Mo, K Wang, B McConeghy, S Brahmbhatt, L Jong, ...
Genome biology 15, 1-14, 2014
942014
SseL Is a Salmonella-Specific Translocated Effector Integrated into the SsrB-Controlled Salmonella Pathogenicity Island 2 Type III Secretion System
BK Coombes, MJ Lowden, JL Bishop, ME Wickham, NF Brown, N Duong, ...
Infection and immunity 75 (2), 574-580, 2007
922007
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer
A Davies, S Nouruzi, D Ganguli, T Namekawa, D Thaper, S Linder, ...
Nature cell biology 23 (9), 1023-1034, 2021
802021
Hsp27 regulates EGF/β‐catenin mediated epithelial to mesenchymal transition in prostate cancer
T Cordonnier, JL Bishop, M Shiota, KM Nip, D Thaper, S Vahid, D Heroux, ...
International journal of cancer 136 (6), E496-E507, 2015
762015
Salmonella phage ST64B encodes a member of the SseK/NleB effector family
NF Brown, BK Coombes, JL Bishop, ME Wickham, MJ Lowden, O Gal-Mor, ...
PLoS One 6 (3), e17824, 2011
712011
Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance
M Nouri, J Caradec, AA Lubik, N Li, BG Hollier, M Takhar, ...
Oncotarget 8 (12), 18949, 2017
702017
Regulation of tumor cell plasticity by the androgen receptor in prostate cancer
JL Bishop, A Davies, K Ketola, A Zoubeidi
Endocr Relat Cancer 22 (3), R165-R182, 2015
562015
Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer
S Vahid, D Thaper, KF Gibson, JL Bishop, A Zoubeidi
Scientific reports 6 (1), 31842, 2016
532016
Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancer
M Shiota, JL Bishop, A Takeuchi, KM Nip, T Cordonnier, E Beraldi, ...
Oncotarget 6 (11), 9086, 2015
442015
Lyn activity protects mice from DSS colitis and regulates the production of IL-22 from innate lymphoid cells
JL Bishop, ME Roberts, JL Beer, M Huang, MK Chehal, X Fan, LA Fouser, ...
Mucosal immunology 7 (2), 405-416, 2014
402014
Friend or foe? Antimicrobial peptides trigger pathogen virulence
JL Bishop, BB Finlay
Trends in molecular medicine 12 (1), 3-6, 2006
402006
Lyn tyrosine kinase regulates androgen receptor expression and activity in castrate-resistant prostate cancer
A Zardan, KM Nip, D Thaper, P Toren, S Vahid, E Beraldi, L Fazli, ...
Oncogenesis 3 (8), e115-e115, 2014
362014
The system can't perform the operation now. Try again later.
Articles 1–20